PITTSBURGH, Dec. 7 /PRNewswire/ -- The Board of Directors of the Pittsburgh Life Sciences Greenhouse (PLSG), the organization providing capital investments and customized company formation and business growth services to the region's life sciences enterprises, today announced the approval of the nomination of Dr. D. Lansing Taylor as the new Chairman of the Board of the PLSG.
In making the announcement, outgoing Co-Chairs Mark Nordenberg and Dr. Jared Cohon remarked, "We are extremely proud to hand over the leadership of the PLSG Board to Lans. He is an exceptional regional advocate for the development of life sciences innovation, a seasoned entrepreneur and an exemplary leader. We look forward to a productive and successful year, and we welcome our new board chair as we continue our work to establish the Pittsburgh region as a dominant player in the life sciences."
As incoming Chairman of the Board Dr. Taylor said, "I am honored to work with such a tremendous group of board members and PLSG staff and I am confident we can make 2008 one of the most proactive and defining years in PLSG's history. We will build on the momentum and accomplishments set forth by Chancellor Nordenberg and President Cohon to commercialize life sciences technologies while providing an improved quality of life for the world's citizens."
The Board also thanked Dr. Cohon and Chancellor Nordenberg for their 5+ years of dedication and service as the founding Co-Chairs of the PLSG. Mr. John W. Manzetti, President and CEO of the PLSG added, "The PLSG has made great progress under the direction of Dr. Cohon and Chancellor Nordenberg, with over 200 life sciences companies in the PLSG portfolio and $9.5M of direct investments in more than 45 companies." Mr. Manzetti further commented, "The Co-Chairs have been exceptionally supportive and have contributed greatly in the repositioning of the PLSG since I joined as CEO. Without their help, we could not have made the impact nor accomplished the goals we have over the past year."
About the Pittsburgh Life Sciences Greenhouse (PLSG)
The PLSG invests in and supports the growth of biosciences companies in southwestern Pennsylvania. The PLSG has investment and business growth programs to increase the linkage between research, technology and commercialization; nurture and develop entrepreneurial biosciences enterprises; grow the region's talent pool in the life sciences; and help biosciences firms locate, expand or start-up in the Greater Pittsburgh region. http://www.plsg.com
D. Lansing Taylor, Ph.D., PLSG Chairman of the Board
Dr. Taylor is the President and CEO of Cellumen, Inc. Dr. Taylor was the Founder, Chairman, and CEO of Cellomics, Inc. which was acquired by ThermoFisher Scientific. He was a co-founder, member of the Board, and a scientific advisor to Biological Detection Systems, Inc. until it was sold to Amersham Biosciences in 1996. Dr. Taylor was a Professor of Biological Sciences, Vice Dean of Molecular Sciences, and Director of the National Science Foundation, Science and Technology Center (STC) at Carnegie Mellon between 1982 and 1996. He was a pioneer in the development of instrumentation and fluorescence-based reagents to measure the functions of living cells. He continues as an Adjunct Professor at Carnegie Mellon. Dr. Taylor began his academic and research career at Harvard University.
Dr. Taylor is on the Board of Directors of the Pittsburgh Life Sciences Greenhouse, NetHealth Systems, Inc., PA BIO, and Celsense, Inc. He received the 1996 Computer World, Smithsonian Award in Science for the work performed by the STC on functional imaging of live cells. He was named entrepreneur of the year in Western Pennsylvania by Ernst and Young in 2001 and entrepreneur of the year in 2002 by the Carnegie Science Center and the Pittsburgh Technology Council.
Dr. Taylor holds more than 12 patents.
|SOURCE Pittsburgh Life Sciences Greenhouse|
Copyright©2007 PR Newswire.
All rights reserved